Being held at the Palais des congres in Montreal.

ART to record on its molecular imaging products research at the Globe Molecular Imaging Congress ART Advanced Research Systems Inc. , a Canadian medical device business and a leader in optical molecular imaging items for the health care and pharmaceutical sectors, announced today that current analysis relating to its molecular imaging items will be provided at poster sessions at the World Molecular Imaging Congress , being held at the Palais des congres in Montreal, Canada, from September 23 to 26, 2009. Both items are based on the proprietary time domain technology produced by ART, that allows for more accurate recovery of concentration and depth than additional optical systems.Individuals with chronic pancreatitis are at risk for pancreatic malignancy and should be adopted up by a gastroenterologist or a pancreatic surgeon. Percutaneous biopsy should not be performed prior to assessment of resectability due to the risk of the tumour seeding along the needle system and therefore eliminating any potential for cure.. ATSP-9172 exhibits on-target binding activity in human prostate cancer model Aileron Therapeutics, Inc. These data will end up being shown today in a late-breaking poster presentation titled, ATSP-9172, a novel Stapled Peptide inhibitor of HIF-dependent transcriptional activity with in vivo antitumor efficacy in a preclinical model of prostate tumor, at the American Association for Tumor Analysis Annual Meeting 2013, abstract number LB-304.